| [1] |
Kheiwa A, Hari P, Madabhushi P, et al. Patent foramen ovale and atrial septal defect[J]. Echocardiography, 2020, 37(12):2172-2184.
|
| [2] |
Homma S, Messé SR, Rundek T, et al. Patent foramen ovale[J]. Nat Rev Dis Primers, 2016, 2:15086.
|
| [3] |
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts[J]. Mayo Clin Proc, 1984, 59(1):17-20.
|
| [4] |
Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank[J]. Ann Neurol, 1989, 25(4):382-390.
|
| [5] |
Kim SJ, Shin HY, Ha YS, et al. Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the cause of silent cerebral infarction in healthy subjects)[J]. Eur J Neurol, 2013, 20(2):353-360.
|
| [6] |
Arslan A, Yılmaz DÇ, Adıyaman M, et al. Study of transesophageal echocardiography in young patients with cryptogenic stroke: prevalence of patent foramen ovale and interpretation of the RoPE score[J]. Turk Kardiyol Dern Ars, 2022, 50(5):314-319.
|
| [7] |
Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study[J]. Circulation, 2002, 105(22):2625-2631.
|
| [8] |
Pires M, Almeida I, Santos JM, et al. Thrombus in transit through a patent foramen ovale: catch it if you can-a case report[J]. Eur Heart J Case Rep, 2021, 5(10):ytab382.
|
| [9] |
Yan C, Li H, Wang C, et al. Frequency and size of in situ thrombus within patent foramen ovale[J]. stroke, 2023,54(5):1205-1213.
|
| [10] |
Yan C, Li H. Preliminary investigation of in situ thrombus within patent foramen ovale in patients with and without stroke[J]. JAMA, 2021,325(20):2116-2118.
|
| [11] |
Stecco A, Quagliozzi M, Soligo E, et al. Can neuroimaging differentiate PFO and AF-related cardioembolic stroke from the other embolic sources? Clinical-radiological correlation on a retrospective study[J]. Radiol Med, 2017, 122(6):412-418.
|
| [12] |
Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after Stroke[J]. N Engl J Med, 2017, 377(11):1011-1021.
|
| [13] |
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[J]. N Engl J Med, 2017, 377(11):1033-1042.
|
| [14] |
Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial[J]. J Am Coll Cardiol, 2018, 71(20):2335-2342.
|
| [15] |
Wintzer-Wehekind J, Alperi A, Houde C, et al. Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism[J]. J Am Coll Cardiol, 2019, 73(3):278-287.
|
| [16] |
Messé SR, Gronseth GS, Kent DM, et al. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: report of the guideline Subcommittee of the American Academy of Neurology[J]. Neurology, 2020, 94(20):876-885.
|
| [17] |
Kavinsky CJ, Szerlip M, Goldsweig AM, et al. SCAI guidelines for the management of patent foramen ovale[J]. JSCAI, 2022, 1 (4): p.100039.
|
| [18] |
张玉顺, 蒋世良, 朱鲜阳. 卵圆孔未闭相关卒中预防中国专家指南[J]. 心脏杂志, 2021, 33(1):1-10.
|
| [19] |
Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study[J]. Cerebrovasc Dis, 1998, 8(6):327-330.
|
| [20] |
Liu K, Wang BZ, Hao Y, et al. The correlation between migraine and patent foramen ovale[J]. Front Neurol, 2020, 11:543485.
|
| [21] |
Iwasaki A, Suzuki K, Takekawa H, et al. Prevalence of right to left shunts in Japanese patients with migraine: a single-center study[J]. Intern Med, 2017, 56(12):1491-1495.
|
| [22] |
Ozge A, Ozge C, Oztürk C, et al. The relationship between migraine and atopic disorders-the contribution of pulmonary function tests and immunological screening[J]. Cephalalgia, 2006, 26(2):172-179.
|
| [23] |
Reiter R, Bertog SG, Vaskelyte L, et al. PFO closure: rational, procedure and devices[J]. Minerva Cardioangiol, 2014, 62(1):83-97.
|
| [24] |
Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with STARFlex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache[J]. Circulation, 2008, 117(11):1397-1404.
|
| [25] |
Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: The PREMIUM Trial[J]. J Am Coll Cardiol, 2017, 70(22):2766-2774.
|
| [26] |
Rayhill M, Burch R. PFO and migraine: Is there a role for closure?[J]. Curr Neurol Neurosci Rep, 2017, 17(3):20.
|
| [27] |
Zhang Y, Wang H, Liu L. Patent foramen ovale closure for treating migraine: a meta-analysis[J]. J Interv Cardiol, 2022, 2022:6456272.
|
| [28] |
Pristipino C, Germonpré P, Toni D, et al. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions[J]. Eur Heart J. 2021, 42(16):1545-1553.
|
| [29] |
Germonpré P, Lafère P, Portier W, et al. Increased risk of decompression sickness when diving with a right-to-left shunt: Results of a prospective single-blinded observational study (The "Carotid Doppler" Study)[J]. Front Physiol, 2021, 12:763408.
|
| [30] |
Abdelfattah OM, Sayed A, Elgendy IY, et al. Patent foramen ovale closure and decompression sickness among divers[J]. Cardiovasc Revasc Med, 2022, 40:160-162.
|
| [31] |
Smart D, Mitchell S, Wilmshurst P, et al. Joint position statement on persistent foramen ovale (PFO) and diving. South Pacific Underwater Medicine Society (SPUMS) and the United Kingdom Sports Diving Medical Committee (UKSDMC)[J]. Diving Hyperb Med, 2015, 45(2):129-131.
|
| [32] |
Mojadidi MK, Ruiz JC, Chertoff J, et al. Patent foramen ovale and hypoxemia[J]. Cardiol Rev, 2019, 27(1):34-40.
|
| [33] |
Hacievliyagil SS, Gunen H, Kosar FM, et al. Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease[J]. Respir Med, 2006, 100(5):903-910.
|
| [34] |
Mojadidi MK, Bokhoor PI, Gevorgyan R, et al. Sleep apnea in patients with and without a right-to-left shunt[J]. J Clin Sleep Med, 2015, 11(11):1299-1304.
|
| [35] |
Robl J, Vutthikraivit W, Horwitz P, et al. Percutaneous closure of patent foramen ovale for treatment of hypoxemia: a case series and physiology review[J]. Catheter Cardiovasc Interv, 2022, 100(3):471-475.
|
| [36] |
Kleber FX, Hauschild T, Schulz A, et al. Epidemiology of myocardial infarction caused by presumed paradoxical embolism via a patent foramen ovale[J]. Circ J, 2017, 81(10):1484-1489.
|
| [37] |
Cavaliere M, De Luca P, Scarpa A, et al. SCORE risk scale as a prognostic factor after sudden sensorineural hearing loss[J]. Eur Arch Otorhinolaryngol, 2020, 277(3):953-954.
|
| [38] |
Haggiag S, Prosperini L, Stasolla A, et al. Ozone-induced encephalopathy: a novel iatrogenic entity[J]. Eur J Neurol, 2021, 28(8):2471-2478.
|
| [39] |
Adamo D, Calabria E, Coppola N, et al. When orofacial pain needs a heart repair[J]. Clin Exp Dent Res, 2021, 7(2):263-267.
|
| [40] |
Yamashita E, Murata T, Goto E, et al. Inferior vena cava compression as a novel maneuver to detect patent foramen ovale: a transesophageal echocardiographic study[J]. J Am Soc Echocardiogr, 2017, 30(3):292-299.
|
| [41] |
He JC, Zheng JY, Li X, et al. Transthoracic contrast echocardiography using vitamin B6 and sodium bicarbonate as contrast agents for the diagnosis of patent foramen ovale[J]. Int J Cardiovasc Imaging, 2017, 33(8):1125-1131.
|
| [42] |
Yang X, Wang H, Wei Y, et al. Diagnosis of patent foramen ovale: The combination of contrast transcranial doppler, contrast transthoracic echocardiography, and contrast transesophageal echocardiography[J]. Biomed Res Int, 2020, 2020:8701759.
|
| [43] |
Chen L, Sheng Y, Huang Y, et al. Aortic root downward movement as a novel method for identification of an adequately performed Valsalva maneuver to detect patent foramen ovale during transesophageal echocardiograph[J]. Diagnostics (Basel), 2022, 12(4):980.
|
| [44] |
Xiong L, Zeng Y, Gan T, et al. Assessing patent foramen ovale on coronary computed tomographic angiography: a comparison with transesophageal echocardiography[J]. Jpn J Radiol, 2022, 40(7):689-695.
|
| [45] |
Kavvouras C, Vavuranakis M, Vaina S, et al. Intracardiac echocardiography for percutaneous patent foramen ovale and atrial septal defect occlusion[J]. Herz, 2019, 44(5):445-449.
|
| [46] |
Han Y, Zhang X, Zhang F. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients[J]. J Cardiothorac Surg, 2020, 15(1):11.
|
| [47] |
Yang T, Butera G, Ou-Yang WB, et al. Percutaneous closure of patent foramen ovale under transthoracic echocardiography guidance-midterm results[J]. J Thorac Dis, 2019, 11(6):2297-2304.
|
| [48] |
Iskander B, Anwer F, Oliveri F, et al. Amplatzer patent foramen ovale occluder device-related complications[J]. Cureus, 2022, 14(4):e23756.
|
| [49] |
Aytemir K, Oto A, Ozkutlu S, et al. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience[J]. J Interv Cardiol, 2012, 25(4):375-381.
|
| [50] |
Kumar P, Orford JL, Tobis JM. Two cases of pericardial tamponade due to nitinol wire fracture of a gore septal occluder[J]. Catheter Cardiovasc Interv, 2020, 96(1):219-224.
|
| [51] |
Zhao E, Liu W, Zhang Y, et al. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: a single-center prospective study[J]. Medicine (Baltimore), 2017, 96(14):e6572.
|
| [52] |
Yang K, Lyu JH, Hu HB, et al. Efficacy and safety of a parylene-coated occluder for atrial septal defect: a prospective, multi-center, randomized controlled clinical trial[J]. Chin Med J (Engl), 2021, 134(22):2685-2691.
|
| [53] |
Jux C, Bertram H, Wohlsein P, et al. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device[J]. J Am Coll Cardiol, 2006, 48(1):161-169.
|
| [54] |
Duong-Hong D, Tang YD, Wu W, et al. Fully biodegradable septal defect occluder-a double umbrella design[J]. Catheter Cardiovasc Interv, 2010, 76(5):711-718.
|
| [55] |
Wu W, Yip J, Tang YD, et al. A novel biodegradable septal defect occluder: the "Chinese Lantern" design, proof of concept[J]. Innovations (Phila), 2011, 6(4):221-230.
|
| [56] |
Du Y, Xie H, Shao H, et al. A prospective, single-center, phase I clinical trial to evaluate the value of transesophageal echocardiography in the closure of patent foramen ovale with a novel biodegradable occluder[J]. Front Cardiovasc Med, 2022,9:849459.
|
| [57] |
Lin C, Liu L, Liu Y, et al. Recent developments in next-generation occlusion devices[J]. Acta Biomater, 2021, 128:100-119.
|
| [58] |
Lin C, Lv J, Li Y, et al, 4D-printed biodegradable and remotely controllable shape memory occlusion devices[J]. Adv Funct Mater, 2019, 29: 1906569.
|
| [59] |
Sun W, Wang B, He L, et al. Feasibility and safety of transnasal transesophageal echocardiography guiding left atrial appendage closure without general anesthesia[J]. JACC Cardiovasc Imaging, 2020, 13(9):2043-2044.
|
| [60] |
Maini B. Real-time three-dimensional intracardiac echocardiography: an early single-center experience[J]. J Invasive Cardiol, 2015, 27(1):E5-E12.
|
| [61] |
Gaetti G, Beneduce A, La Fauci D, et al. Suture-mediated patent foramen ovale closure using the NobleStitch EL: Results from a hospital-based HTA[J]. Int J Environ Res Public Health, 2022, 19(13):7863.
|